ESPR Operating Expenses

Esperion Therapeutics Inc · Operating Expenses

ESPR logo

ESPR Operating Expenses

Latest reported$196.07M
ESPR TTM Operating Expenses ($26.79M → $196.07M)
High-resolution chart · PNG

ESPR operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Esperion Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
196,066,000
199,507,000
192,050,000
200,574,000
209,473,000
209,311,000
224,574,000
222,327,000
222,739,000
228,630,000
222,636,000
228,608,000
234,591,000
228,009,000
236,792,000
247,291,000
256,642,000
290,960,000
328,525,000
348,038,000
359,314,000
346,551,000
302,978,000
285,618,000
259,230,000
241,465,000
242,168,000
225,981,000
216,181,000
204,585,000
182,632,000
177,807,000
174,987,000
168,982,000
159,571,000
131,546,000
102,217,000
76,150,000
60,099,000
55,306,000
53,437,000
50,040,000
46,186,000
42,967,000
39,759,000
36,224,000
36,580,016
32,286,839
27,304,686
22,758,698
15,182,729
12,766,155
11,358,189
10,203,760
14,500,713
19,663,464
24,204,583
28,482,000
29,408,000
28,931,000
29,237,000
29,226,000
29,102,000
29,622,000
30,258,000
30,044,000
30,605,000
29,661,000
26,788,128
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.